Contents 1. Executive Summary 2. Live Cell Imaging Market 2.1. Product Overview 2.2. Market Definition 2.3. Segmentation 2.4. Assumptions and Acronyms 3. Research Methodology 3.1. Research Objectives 3.2. Primary Research 3.3. Secondary Research 3.4. Forecast Model 3.5. Market Size Estimation 4. Average Pricing Analysis 5. Macro-Economic Indicators 6. Market Dynamics 6.1. Growth Drivers 6.2. Restraints 6.3. Opportunity 6.4. Trends 7. Correlation & Regression Analysis 7.1. Correlation Matrix 7.2. Regression Matrix 8. Recent Development, Policies & Regulatory Landscape 9. Risk Analysis 9.1. Demand Risk Analysis 9.2. Supply Risk Analysis 10. Live Cell Imaging Analysis 10.1. Porters Five Forces 10.1.1. Threat of New Entrants 10.1.2. Bargaining Power of Suppliers 10.1.3. Threat of Substitutes 10.1.4. Rivalry 10.2. PEST Analysis 10.2.1. Political 10.2.2. Economic 10.2.3. Social 10.2.4. Technological 11. Live Cell Imaging Market 11.1. Market Size & forecast, 2019A-2030F 11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12. Live Cell Imaging: Market Segmentation 12.1. By Regions 12.1.1. North America: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.2. Europe: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.3. Asia-Pacific: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.4. MEA: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.5. Latin America: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2. By Product: Market Share (2020-2030F) 12.2.1. Equipment, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.2. Consumable, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.3. Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3 By Technology: Market Share (2020-2030F) 12.3.1. Time-lapse Microscopy, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.2. Fluorescence recovery after photobleaching, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.3. Fluorescence resonance energy transfer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.4. High content screening (HCS), By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.5. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.4 By Application: Market Share (2020-2030F) 12.4.1. Cell Biology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.4.2. Developmental Biology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.4.3. Stem Cell & Drug Discovery, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.4.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 13. Company Profile 13.1.1. Becton, Dickinson and Company 13.1.2. Company Overview 13.1.3. Company Total Revenue (Financials) 13.1.4. Market Potential 13.1.5. Global Presence 13.1.6. Key Performance Indicators 13.1.7. SWOT Analysis 13.1.8. Product Launch 13.2. Carl Zeiss AG 13.3. GE Healthcare 13.4. Leica Microsystems 13.5. Olympus Corporation 13.6. Molecular Devices LCC 13.7. Nikon Corporation 13.8. PerkinElmer Inc. 13.9. Sigma-Aldrich Corporation 13.10. Thermo Fisher Scientific Inc 14 Consultant Recommendation **The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.